Liver Disease
As many as 3 in 5 people with type 2 diabetes have a build-up of fat in their liver.
Learn about a new clinical research study.
A clinical research study brings people together to gather information to advance science and medicine.
To learn more about this clinical research study, please contact us:
National Research Institute
1-877-720-7474
Is Fatty Liver Disease Hanging Over Your Head?
Along with investigating a potential new treatment option for nonalcoholic steatohepatitis (NASH), a form of severe fatty liver disease, the SYNERGY-NASH Study is also providing resources like lifestyle and weight management counseling.
Are you suffering from a Fatty Liver?
See if you are eligible to participate in a study evaluating an investigational drug for the treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH). To qualify you must:
- be between the ages of 18 and 75
- Have had a liver biopsy or be willing to undergo a liver biopsy
Qualified participants may receive:
Ask us about your liver.
National Research Institute
877.719.6767
14418 Chase Street #200
Panorama CIty, CA 91402
NASH
NASH is an advanced form of fatty liver disease called non-alcoholic steato-hepatitis.
If you have NASH you may be able to participate in this research study. If you qualify, your participation will last up to 6 years with up to 8 office visits in the first year and a half and 2 office visits every year following.
Study drug, study-related and all study tests will be provided at no charge. Eligible participants may also be reimbursed for travel expenses.
